Evidence map›Paper›PMID 22814331›Full record

ArticleTransplantation2012

An isolated venous sac as a novel site for cell therapy in diabetes mellitus.

Zurab Kakabadze, Koba Shanava, Camillo Ricordi, A M James Shapiro, Sanjeev Gupta, Ekaterine Berishvili

Open access · greenAbstract read
In one paragraph

Article in Transplantation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Generation of insulin-secreting organoids: a step toward engineering and transplanting the bioartificial pancreas.Transplant international : official journal of the European Society for Organ Transplantation · 2020
    Review
  4. Decellularized bovine placentome for portacavally-interposed heterotopic liver transplantation in rats.Materials science & engineering. C, Materials for biological applications · 2019
    Article
  5. Article
  6. Article
  7. Re-engineering islet cell transplantation.Pharmacological research · 2015
    Review
  8. Article
  9. Review
  10. Transplantation of pancreatic islets to adrenal gland is promoted by agonists of growth-hormone-releasing hormone.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  11. Bio-Engineering of Pre-Vascularized Islet Organoids for the Treatment of Type 1 Diabetes.Transplant international : official journal of the European Society for Organ Transplantation
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Zurab KakabadzeDepartment of Clinical Anatomy, Tbilisi State Medical University, and Division of Cell Transplantation, Georgian National Institute of Medical Research, DRI Federation, Tbilisi, GA, USA.
Koba Shanava
Camillo Ricordi
A M James Shapiro
Sanjeev Gupta
Ekaterine Berishvili
Tbilisi State Medical University · GEInstitute for Stem Cell Biology and Regenerative Medicine · INUniversity of Alberta · CAUniversity of Miami · US

Funding

Special Animal CoreP30DK041296 · NIDDK · YESHIVA UNIVERSITY · PI WOLKOFF, ALLAN W · 1989 to 2018
$22.9M
Transplantation of Endothelial CellsR01DK071111 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI GUPTA, SANJEEV · 2006 to 2016
$3.6M
Cell transplantation and inflammationR01DK088561 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI GUPTA, SANJEEV · 2011 to 2014
$1.7M
NIDDK NIH HHS P30 DK041296NIDDK NIH HHS R01 DK071111NIDDK NIH HHS R01 DK088561
6 · The paper itself

Abstract

backgroundTransplanting pancreatic islets is of significant interest for type 1 diabetes mellitus. After intraportal injection of islets, inferior engraftment and eventual loss of transplanted islets constitute major limitations. Therefore, alternative approaches will be helpful. Here, we evaluated in animals whether an isolated venous sac would support survival of transplanted islets, along with correction of hyperglycemia.

methodsPancreatic islets isolated from adult Lewis rats were transplanted either into an isolated venous sac made from lumbar vein or into the portal vein of syngeneic rats. The integrity and vascular organization of the venous sac was determined by studies of the local microcirculation. The engraftment, survival, and function of transplanted islets were analyzed by histology, including endocrine function in situ and by glycemic control in rats with streptozotocin-induced diabetes.

resultsTransplanted islets showed normal morphology with insulin expression in isolated venous sac during the long term. Transplanted islets received blood supply from vasa vasorum and had access to drainage through venous tributaries in the venous sac. This resulted in restoration of euglycemia in diabetic rats. Removal of islet graft-bearing venous sac in diabetic rats led to recurrence of hyperglycemia. By contrast, euglycemia was not restored in rats treated by intraportal transplantation of islets.

conclusionsWe demonstrated that pancreatic islets successfully engrafted and functioned in the isolated venous sac with ability to restore euglycemia in diabetic rats. Therefore, the isolated venous sac offers a new site for transplantation of pancreatic islets. This would be clinically beneficial as an alternative to intrahepatic islet transplantation.

Indexed as

AnimalsDiabetes Mellitus, ExperimentalGlucose Tolerance TestIslets of Langerhans TransplantationMalePortal VeinRatsRats, Inbred LewSaphenous VeinStreptozocinStreptozocin

Identifiers

PMID22814331
PMCPMC3680102
OpenAlexW1969103692

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.